MedPath

Investigation of the effects of imeglimin administration on the metabolism of mitochondrial diabetes mellitus

Not Applicable
Conditions
mitochondrial diabetes
Registration Number
JPRN-UMIN000053289
Lead Sponsor
Department of Medicine, Division of Diabetes, Endocrinology and Metabolism, Kimitsu Chuo Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Female
Target Recruitment
1
Inclusion Criteria

Not provided

Exclusion Criteria

nothing

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement of HbA1c 12 weeks after the start of administration
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath